|
521
|
|
|
Plexin A2 |
OCT, PLXN2 |
Attention deficit hyperactivity disorder, Liver cirrhosis, Neurodevelopmental disorder, Crohn disease, Inflammatory bowel disease, Metabolic syndrome, Kawasaki disease, Non-specific syndromic intellectual disability, Obesity, Willis-ekbom disease, Schizophrenia, Scoliosis, Substance abuse, Diabetes mellitus, type 2, Ulcerative colitis |
|
522
|
|
|
Protein kinase AMP-activated non-catalytic subunit gamma 3 |
AMPKG3, SMGMQTL |
|
|
523
|
|
|
PTOV1 extended AT-hook containing adaptor protein |
ACID2, PTOV-1 |
|
|
524
|
|
|
Plexin B1 |
PLEXIN-B1, PLXN5, SEP |
|
|
525
|
|
|
Phorbol-12-myristate-13-acetate-induced protein 1 |
APR, NOXA |
|
|
526
|
|
|
Pro-melanin concentrating hormone |
MCH, ppMCH |
|
|
527
|
|
|
Prepronociceptin |
N/OFQ, NOP, OFQ, PPNOC, ppN/OFQ |
Major depressive disorder, Hyperalgesia, Hypotension, Learning disorders, Memory disorders, Depression, Metabolic syndrome, Mood disorder, Parkinson disease, Substance abuse, Diabetes mellitus, type 2 |
|
528
|
|
|
PML nuclear body scaffold |
MYL, PP8675, RNF71, TRIM19 |
Diabetes mellitus, Dyslipidemias, Glioblastoma, Insomnia, Promyelocytic leukemia, Liver neoplasm, Metabolic syndrome, Prostatic neoplasm, Schizophrenia, Stevens-johnson syndrome, Diabetes mellitus, type 2, Uterine fibroid |
|
529
|
|
|
Phosphomannomutase 2 |
CDG1, CDG1a, CDGS, PMI, PMI1, PMM 2 |
Breast cancer, Cerebellar ataxia, Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, Cerebral atrophy, Cerebral palsy, Colorectal neoplasm, Congenital disorder of glycosylation, Diabetes mellitus, Focal glomerulosclerosis, Hyperinsulinemic hypoglycemia, Intellectual developmental disorder, Muscular dystrophy, Open angle glaucoma, Premature ovarian failure, Pituitary stalk interruption syndrome |
|
530
|
|
|
Peripheral myelin protein 2 |
CMT1G, FABP8, M-FABP, MP2, P2 |
|
